CARDIFF ONCOLOGY INC (CRDF) Stock Income Statement
USA - NASDAQ:CRDF - US14147L1089 - Common Stock
2.35 USD
+0.12 (+5.38%)
2.34 USD
-0.01 (-0.43%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 546.00K | 683.00K | 488.00K | 390.00K | 360.00K | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 54.88M | 49.33M | 45.90M | 40.29M | 29.21M | |||
| Research and Development | 41.41M | 36.85M | 32.86M | 27.11M | 17.38M | |||
| Selling, General, and Administrative Expenses | 13.47M | 12.48M | 13.04M | 13.18M | 11.84M | |||
| Operating Income | -54.33M | -48.65M | -45.41M | -39.90M | -28.86M | |||
| Interest Income/Expense | 3.30M | 3.26M | 4.07M | 1.58M | 550.00K | |||
| Other Income/Expense | 9.00K | -39.00K | -98.00K | -380.00K | 20.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -51.02M | -45.43M | -41.44M | -38.70M | -28.29M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -51.04M | -45.45M | -41.47M | -38.73M | -28.32M | |||
| EBITDA | -53.95M | -48.25M | -45.01M | -39.66M | -28.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.88 | -0.95 | -0.93 | -0.89 | -0.73 | |||
| Non GAAP EPS | -0.88 | -0.95 | -0.93 | -0.89 | -0.71 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -9348.53% | -6655.20% | -8496.93% | -9930.77% | -7866.67% | |||
| Operating Profit Margin | -9950.92% | -7123.13% | -9305.74% | -10230.77% | -8016.67% | |||
All data in USD